whi p154 has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
WHI P154: an anti-leukemic agent; structure in first source
Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho-Vega, JH | 1 |
| Rassidakis, GZ | 1 |
| Amin, HM | 1 |
| Tsioli, P | 1 |
| Spurgers, K | 1 |
| Remache, YK | 1 |
| Vega, F | 1 |
| Goy, AH | 1 |
| Gilles, F | 1 |
| Medeiros, LJ | 1 |
1 other study available for whi p154 and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.
Topics: Alternative Splicing; Anaplastic Lymphoma Kinase; DNA-Binding Proteins; Gene Expression Profiling; G | 2004 |